RPT-01
Email
Canadian Market Access Landscape
The quarterly Canadian reimbursement briefing — Health Canada NOCs, CDA-AMC reviews, INESSS recommendations, and pCPA negotiations across the access pathway, plus the emerging impact of U.S. MFN drug pricing.
Quarterly Briefing Q2 2026 19 pp